erythrosine has been researched along with Nephrosis, Lipoid in 1 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Nephrosis, Lipoid: A kidney disease with no or minimal histological glomerular changes on light microscopy and with no immune deposits. It is characterized by lipid accumulation in the epithelial cells of KIDNEY TUBULES and in the URINE. Patients usually show NEPHROTIC SYNDROME indicating the presence of PROTEINURIA with accompanying EDEMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertelli, R | 1 |
| Bodria, M | 1 |
| Nobile, M | 1 |
| Alloisio, S | 1 |
| Barbieri, R | 1 |
| Montobbio, G | 1 |
| Patrone, P | 1 |
| Ghiggeri, GM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of IL-2 for Pediatric, Multi Drug Resistant, Idiopathic Nephrotic Syndrome[NCT02455908] | Phase 1/Phase 2 | 5 participants (Actual) | Interventional | 2012-02-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for erythrosine and Nephrosis, Lipoid
| Article | Year |
|---|---|
Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome.
Topics: Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Antigens, CD; Apyrase; CD4 Lymphocyte Cou | 2011 |